Massive study tests which diabetes pill better protects failing hearts
NCT ID NCT07390110
Summary
This study analyzes existing health insurance records to compare two common type 2 diabetes medications, oral semaglutide and sitagliptin. It aims to see which drug is more effective at preventing serious heart failure complications, like hospitalization, in people who have both diabetes and a specific type of heart failure. The research uses data from over 25,000 patients to understand real-world effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02120, United States
Conditions
Explore the condition pages connected to this study.